fbpx Skip to main content

An industry united against COVID-19

Return to Work Resource Center Partnering Opportunities

2020 EIR

View our 2020 California Life Science Economic Impact Report

Take Action

Help support international students, scholars, and researchers


2020: A Glimpse Into the Regulatory Landscape

2020 will inherit many industry challenges, and it will also bring new ones. From drug pricing to a new Food and Drug Administration (FDA) Commissioner, a wave of policies and reforms will impact California’s life sciences this year.

Biocom’s Advocacy team takes a look at what’s ahead in the coming year.

Read More



Biocom offices are located in the heart of several California life science clusters, as well as areas key to our many active public policy initiatives. Headquartered in San Diego, Biocom’s additional locations are in Los Angeles, the Bay Area, Washington, D.C., and Tokyo.

Learn More

Biocom Ribbon Cutting


Take advantage of 30+ RFP-vetted life science-related contracts.


2020 EIR
Learn More

View our 2020 California Life Science Economic Impact Report

Return to Work Guide
Learn More

Download The Path Forward: Biocom’s Return to Work Guide for CA’s Life Science Industry

2020 HR Conference
Learn More

Save the date for the 2020 Biocom Life Science HR Conference

Podcast: International Pricing Index Impact
Learn More

Biocom’s Joseph Panetta Discusses the Impact of IPI with the Vital Health Podcast

“I have had the opportunity to give presentations to VCs and Pharma Venture Funds at several Venture Day events. These experiences have been very helpful with respect to meeting investors from outside the San Diego area and also for valuable feedback. This is an important Biocom program!”
Michael J. Newman, CEO, Decoy Biosystems
“The LSYL (Life Science Young Leaders) series is a terrific idea. It’s just easier to make meaningful connections among contemporaries and this series is a great platform for that. I look forward to the next one.”
Brendan McCarthy, Attorney, Gunderson Dettmer Stough Villeneuve Franklin & Hachigan
“I was impressed with Biocom’s DeviceFest & Digital Health Conference on August 29th, 2018. The conference had a balance view of content and discussion time with industry experts, which allowed us to have deeper introductory meetings, which will lead to deeper relationships with experts from all over North America. Great job by the planning committee and the management of Biocom.”
Dipak Shah, Board Member, Obsidio Therapeutics, Inc.


Subscribe to Biocom newsletters tailored to your interests.